Search Results for: SRAX

Early Wednesday, Social Reality, Inc. (NASDAQ: SRAX), an Internet advertising and platform technology company focused on the development and commercialization of tools to automate the digital advertising market, announced its entry into a securities purchase agreement that’s expected to generate gross proceeds of $4 million. These proceeds, derived from a collection of fundamental institutional investors, … Continue reading “Social Reality, Inc. (NASDAQ: SRAX) Strengthens Balance Sheet through Entry into $4 Million Securities Purchase Agreement”

Social Reality, Inc. (NASDAQ: SRAX) is an Internet advertising company that has developed SRAX, a real-time bidding (RTB) management platform that, among other capabilities, increases the efficiency with which online publishers are able to capitalize on programmatic advertising auctions. In November, a new whitepaper (http://nnw.fm/m3LAi) sponsored by Xaxis, in conjunction with IDC, expanded upon the … Continue reading “As Social Reality (NASDAQ: SRAX) Completes “Pivotal Year” New White Paper Suggests Trend in Programmatic Growth”

Social Reality, Inc. (NASDAQ: SRAX) is an Internet advertising company focused on providing tools that automate the digital advertising market. The company has developed three core platforms to deliver a complete set of marketing tools and services that create new and measurable opportunities for brands, agencies and publishers to target, reach and monetize their audiences. … Continue reading “Social Reality, Inc. (NASDAQ: SRAX) is “One to Watch””

BiondVax summarizes collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen to discover and develop nanosized antibody (NanoAb) therapies that address underserved and growing markets, including COVID-19, psoriasis, asthma, psoriatic arthritis and wet macular degeneration. The global COVID-19 therapy market was valued at $16.8 billion in 2021 and … Continue reading “BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Director of Communications and Investor Relations Presents at LD Micro Main Event”

Lexaria has multiple studies planned that will commence early in 2022 DehydraTECH increases Lexaria’s ability to leverage multiple markets, including the growing CBD sector, which is expected to meet and exceed $108 billion in revenue by 2027 DehydraTECH can increase the efficacy of the drugs being administered, offering faster absorption and lowering the delivery time … Continue reading “After a Successful 2021, Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks Off 2022 With New Media Strategy, Plans for Clinical Study Advancements”

In September 2020, SRAX acquired LD Micro, a leader in in small- and micro-cap conferences. After almost two years of virtual-only conferences because of COVID-19 restrictions, this year’s main event is both in-person and virtual LD Micro is utilizing technology of a multitude of presenting public companies to ensure the safety and comfort of all … Continue reading “Presenters at LD Micro Main Event, Offer Investment Opportunity, Ensure Attendees’ Comfort and Safety at Same Time”

Live Streaming Event Date: 8,9, 10 June 2021 The LD Micro Invitational XI Virtual Event will be held in June, from 8th to 10th. Companies, shareholders, and investors of the small-cap trading community are invited to attend this influential conference that is addressed by some eminent industry stalwarts.  The 3-day itinerary of the event is … Continue reading “LD Micro Invitational XI Virtual Event Offers A Unique Opportunity For Mid-Cap Companies To Connect With Investor Base”